Kalvista Pharmaceuticals, Inc.
KALV
Revenue
3.82M
▲2.25M▲142.49%
3 Months ChangeAssets
200.20M
▼-35.21M▼-14.96%
3 Months ChangeLiabilities
1.93M
▼-45.00k▼-2.28%
3 Months ChangeFree Cash Flow
-40.24M
▼-13.51M▼-50.51%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0000950170-24-112904
2024-09-10
Form 8-K
ID: 0000950170-24-105182
2024-09-05
Form 8-K
ID: 0000950170-24-104032
2024-09-05
Form 10-Q
ID: 0000950170-24-103981
2024-07-23
Form 8-K
ID: 0000950170-24-085653
2024-07-11
Form 8-K
ID: 0000950170-24-082997
2024-04-22
Form 8-K
ID: 0000950170-24-046481
2024-03-11
Form 8-K
ID: 0000950170-24-029342
2024-03-11
Form 10-Q
ID: 0000950170-24-029314
2024-03-07
Form 8-K
ID: 0001193125-24-061344